Camylofin: Difference between revisions
(Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443763785 | IUPAC_name = isopentyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate | image = Ca...") |
m (Protected "Camylofin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 52: | Line 52: | ||
| molecular_weight = 320.47 g/mol | | molecular_weight = 320.47 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Camylofin''' is an [[antimuscarinic]]. | '''Camylofin''' is an [[antimuscarinic]]. | ||
It is used to treat stomach ache in infants and children. Usually it is given in combination with paracetamol to treat stomach ache, as well as [[pyrexia]]. | It is used to treat stomach ache in infants and children. Usually it is given in combination with paracetamol to treat stomach ache, as well as [[pyrexia]]. | ||
==References== | |||
{{Reflist|2}} | |||
{{Drugs for functional gastrointestinal disorders}} | {{Drugs for functional gastrointestinal disorders}} | ||
[[Category:Amines]] | [[Category:Amines]] | ||
[[Category:Carboxylate esters]] | [[Category:Carboxylate esters]] | ||
[[Category:Drug]] | |||
Latest revision as of 18:32, 18 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H32N2O2 |
Molar mass | 320.47 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Camylofin |
Articles |
---|
Most recent articles on Camylofin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Camylofin at Clinical Trials.gov Clinical Trials on Camylofin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Camylofin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Camylofin Discussion groups on Camylofin Directions to Hospitals Treating Camylofin Risk calculators and risk factors for Camylofin
|
Healthcare Provider Resources |
Causes & Risk Factors for Camylofin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Camylofin is an antimuscarinic.
It is used to treat stomach ache in infants and children. Usually it is given in combination with paracetamol to treat stomach ache, as well as pyrexia.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Amines
- Carboxylate esters
- Drug